Guardant Health, Inc.
Guardant Health, Inc. (GH) — Form 144: Proposed sale of shares
AI-generated summary
Director Tariq Musa of Guardant Health, Inc. proposed to sell 116 shares of common stock with an aggregate market value of $17,349 through broker Charles Schwab & Co., Inc. The shares were originally acquired through a restricted stock lapse on September 15, 2026. The proposed sale is scheduled for November 16, 2026.
Key facts
- Seller
- Tariq Musa
- Relationship
- Director
- Shares to sell
- 116
- Market value
- $17,349.00
- Approximate sale date
- Nov 16, 2026
- Broker
- Charles Schwab & Co., Inc.
- Acquired
- Sep 15, 2026 · Restricted Stock Lapse
Rule 10b5-1 plan · adopted Dec 17, 2025
More GH filings
- 4
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 18, 2026
- 4
Filed Nov 17, 2026
- 4
Filed Nov 17, 2026
- 144
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.